Request Legal Help Now - Free

Advertisement
LAWSUITS NEWS & LEGAL INFORMATION

866 Patent Settlement

New York, NY: (Dec-07-07) Yeda Research and Development Company Ltd. brought charges against ImClone Systems, Inc. and Sanofi-Aventis, alleging that the companies infringed on its patents. As part of a settlement reached, the parties agreed that Yeda is the sole owner of the 866 Patent in the US and that Yeda and Sanofi-Aventis are co-owners of the 866 Patent's foreign counterparts. Additionally, both ImClone and Sanofi-Aventis agreed to pay Yeda $60.0 million each, in cash for full and final settlement of the claims and counterclaims in the matter. As part of the agreement, ImClone shall be granted a worldwide license to technology patented under the 866 Patent. ImClone also stated that it would make a contingent payment to Yeda of a low single-digit royalty on sales in and outside of the US and would pay Sanofi-Aventis a low single-digit royalty on sales outside US. ImClone's worldwide royalty rate for ERBITUX sales pursuant to the settlement agreement remains unchanged. [YAHOO: 866 PATENT INFRINGEMENT]


Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.
Published on Dec-11-07


ADD YOUR COMMENT ON THIS ISSUE

Please read our comment guidelines before posting.


Note: Your name will be published with your comment.


Your email will only be used if a response is needed.

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Legal Help Now! - Free